163 related articles for article (PubMed ID: 3806162)
21. Relationship of [3H]Ara-C incorporation and response to therapy with high-dose Ara-C in AML patients: a Leukemia Intergroup study.
Raza A; Gezer S; Anderson J; Lykins J; Bennett J; Browman G; Goldberg J; Larson R; Vogler R; Preisler HD
Exp Hematol; 1992 Nov; 20(10):1194-200. PubMed ID: 1426099
[TBL] [Abstract][Full Text] [Related]
22. Changes in the characteristics of the bone marrow during therapy for acute non-lymphocytic leukemia: relationship to response to remission induction therapy.
Preisler HD; Raza A; Azarnia N; Rakowsky I; Barcos M; Browman G; Booker L; Goldberg J; Gottleib A; Brennan J
Eur J Cancer Clin Oncol; 1985 May; 21(5):563-71. PubMed ID: 3859416
[TBL] [Abstract][Full Text] [Related]
23. A critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes.
Cheson BD; Jasperse DM; Simon R; Friedman MA
J Clin Oncol; 1986 Dec; 4(12):1857-64. PubMed ID: 3537219
[TBL] [Abstract][Full Text] [Related]
24. Central nervous system (CNS) leukemia: the role of high dose cytarabine (HDAra-C).
Morra E; Lazzarino M; Alessandrino EP; Inverardi D; Regazzi Bonora M; Pagnucco G; Orlandi E; Bernasconi P; Canevari A; Rondanelli R
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():101-3. PubMed ID: 2713552
[TBL] [Abstract][Full Text] [Related]
25. High-dose cytosine arabinoside and L-asparaginase therapy for poor-risk adult acute nonlymphocytic leukemia. A retrospective study.
Evans C; Winkelstein A; Rosenfeld CS; Zeigler ZR; Shadduck RK
Cancer; 1990 Jun; 65(12):2624-30. PubMed ID: 2340464
[TBL] [Abstract][Full Text] [Related]
26. Treatment of poor risk acute leukemia with sequential high-dose ARA-C and asparaginase.
Capizzi RL; Poole M; Cooper MR; Richards F; Stuart JJ; Jackson DV; White DR; Spurr CL; Hopkins JO; Muss HB
Blood; 1984 Mar; 63(3):694-700. PubMed ID: 6696996
[TBL] [Abstract][Full Text] [Related]
27. Systemic high-dose ara-C for the treatment of meningeal leukemia in adult acute lymphoblastic leukemia and non-Hodgkin's lymphoma.
Morra E; Lazzarino M; Inverardi D; Brusamolino E; Orlandi E; Canevari A; Pagnucco G; Bernasconi C
J Clin Oncol; 1986 Aug; 4(8):1207-11. PubMed ID: 3461134
[TBL] [Abstract][Full Text] [Related]
28. [Value of high-dose cytosine-arabinoside in the treatment of resistant acute leukemia].
Witz F; Olive D; Lederlin P; Bordigoni P; Troussard X; Grosbois B; Schaison G; Cornu G
Presse Med; 1987 Feb; 16(4):159-62. PubMed ID: 2950446
[TBL] [Abstract][Full Text] [Related]
29. Prolonged unmaintained remission after intensive consolidation therapy in adult acute nonlymphocytic leukemia.
Cassileth PA; Begg CB; Silber R; Spiers A; Burkart PT; Scharfman W; Knospe WH; Bennett JM; Mazza JJ; Oken MM
Cancer Treat Rep; 1987 Feb; 71(2):137-40. PubMed ID: 3802110
[TBL] [Abstract][Full Text] [Related]
30. Prednimustine and vincristine compared with cytosine arabinoside and thioguanine for treatment of elderly patients with acute nonlymphoblastic leukemia.
Lönnqvist B; Andersson B; Björkholm M; Engstedt L; Gahrton G; Hast R; Holm G; Killander A; Lantz B; Lockner D; Mellstedt H; Palmblad J; Paul C; Peterson C; Simonsson B; Stalfelt AM; Udén AM; Wadman B; Oberg G
Cancer Chemother Pharmacol; 1982; 9(2):89-92. PubMed ID: 7172410
[TBL] [Abstract][Full Text] [Related]
31. [High-dose cytosine arabinoside treatment of leukemia with special reference to the optimal number of doses].
Sampi K; Maseki N; Kumai R; Kaneko Y; Sakurai M; Hattori M
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2595-8. PubMed ID: 2774589
[TBL] [Abstract][Full Text] [Related]
32. Intensified remission induction therapy for acute nonlymphocytic leukemia (ANLL). Treatment report on 60 patients.
Urbanitz D; Büchner T; Kamanabroo D; Hiddemann W; Schulte H; van de Loo J
Blut; 1981 Aug; 43(2):129-33. PubMed ID: 7260406
[TBL] [Abstract][Full Text] [Related]
33. High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: a pilot study.
Wolff SN; Marion J; Stein RS; Flexner JM; Lazarus HM; Spitzer TR; Phillips GL; Herzig RH; Herzig GP
Blood; 1985 Jun; 65(6):1407-11. PubMed ID: 3995177
[TBL] [Abstract][Full Text] [Related]
34. Remission induction in acute nonlymphocytic leukemia: comparison of a seven-day and ten-day infusion of cytosine arabinoside in combination with adriamycin.
Preisler H; Bjornsson S; Henderson ES; Hryniuk W; Higby D; Freeman A; Naeher C
Med Pediatr Oncol; 1979; 7(3):269-75. PubMed ID: 542191
[TBL] [Abstract][Full Text] [Related]
35. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
Early AP; Preisler HD; Slocum H; Rustum YM
Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642
[TBL] [Abstract][Full Text] [Related]
36. Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.
Arlin Z; Case DC; Moore J; Wiernik P; Feldman E; Saletan S; Desai P; Sia L; Cartwright K
Leukemia; 1990 Mar; 4(3):177-83. PubMed ID: 2179638
[TBL] [Abstract][Full Text] [Related]
37. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
[TBL] [Abstract][Full Text] [Related]
38. Complete remission in acute promyelocytic leukemia despite persistence of abnormal bone marrow promyelocytes during induction therapy: experience in 34 patients.
Stone RM; Maguire M; Goldberg MA; Antin JH; Rosenthal DS; Mayer RJ
Blood; 1988 Mar; 71(3):690-6. PubMed ID: 3422828
[TBL] [Abstract][Full Text] [Related]
39. Attenuated high-dose cytosine arabinoside in the treatment of the elderly patient with acute nonlymphocytic leukemia. An Eastern Cooperative Oncology Group Pilot Study.
Kahn SB; Ebrahim K; Cassileth P; Bennett JM; Knospe WH; O'Connell MJ
Am J Clin Oncol; 1989 Jun; 12(3):201-4. PubMed ID: 2729177
[TBL] [Abstract][Full Text] [Related]
40. [High-dose Ara-C treatment of acute leukemia].
Takaku F
Gan To Kagaku Ryoho; 1986 May; 13(5):1823-8. PubMed ID: 3707145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
